Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (351-360 of 386) with videos related to

Pageof 39
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinomaRussell Vang, Kala Visvanathan, Amy Gross, et al.
Breast Cancer Research and Treatment|August 21, 2001
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialC Van Poznak, A D Seidman, M M Reidenberg, et al.
Current Medical Research and Opinion|May 10, 2021
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2- metastatic breast cancerGebra Cuyun Carter, Kristin M Sheffield, Anala Gossai, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancerC A Hudis, A D Seidman, J P Crown, et al.
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancerChau T Dang, Gabriella M D'Andrea, Mary E Moynahan, et al.
Journal of Oncology Practice|January 29, 2019
"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan KetteringJada G Hamilton, Margaux Genoff Garzon, Joy S Westerman, et al.
NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical OncologyMark G Kris, Steven I Benowitz, Sylvia Adams, et al.
Pageof 39

Showing results (351-360 of 386) with videos related to

Sort By:
Pageof 39
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinomaRussell Vang, Kala Visvanathan, Amy Gross, et al.
Breast Cancer Research and Treatment|August 21, 2001
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialC Van Poznak, A D Seidman, M M Reidenberg, et al.
Current Medical Research and Opinion|May 10, 2021
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2- metastatic breast cancerGebra Cuyun Carter, Kristin M Sheffield, Anala Gossai, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancerC A Hudis, A D Seidman, J P Crown, et al.
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancerChau T Dang, Gabriella M D'Andrea, Mary E Moynahan, et al.
Journal of Oncology Practice|January 29, 2019
"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan KetteringJada G Hamilton, Margaux Genoff Garzon, Joy S Westerman, et al.
NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical OncologyMark G Kris, Steven I Benowitz, Sylvia Adams, et al.
Pageof 39